Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Everence Capital Management Inc.

Everence Capital Management Inc. lessened its stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 14.6% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 44,730 shares of the pharmacy operator’s stock after selling 7,640 shares during the period. Everence Capital Management Inc.’s holdings in Walgreens Boots Alliance were worth $417,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of WBA. Sequoia Financial Advisors LLC lifted its holdings in Walgreens Boots Alliance by 4.4% in the third quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock valued at $226,000 after acquiring an additional 1,063 shares during the period. Lincluden Management Ltd. increased its holdings in shares of Walgreens Boots Alliance by 0.4% during the 3rd quarter. Lincluden Management Ltd. now owns 264,644 shares of the pharmacy operator’s stock valued at $2,371,000 after purchasing an additional 1,074 shares in the last quarter. OLD Second National Bank of Aurora lifted its stake in shares of Walgreens Boots Alliance by 35.1% in the 3rd quarter. OLD Second National Bank of Aurora now owns 4,562 shares of the pharmacy operator’s stock valued at $41,000 after purchasing an additional 1,185 shares during the period. PFG Investments LLC boosted its holdings in Walgreens Boots Alliance by 3.8% during the third quarter. PFG Investments LLC now owns 33,916 shares of the pharmacy operator’s stock worth $304,000 after buying an additional 1,245 shares in the last quarter. Finally, Sigma Planning Corp grew its position in Walgreens Boots Alliance by 4.2% during the third quarter. Sigma Planning Corp now owns 31,632 shares of the pharmacy operator’s stock valued at $283,000 after buying an additional 1,282 shares during the period. 58.59% of the stock is owned by institutional investors and hedge funds.

Walgreens Boots Alliance Trading Up 3.4 %

Shares of WBA opened at $9.50 on Monday. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $25.87. The firm has a market capitalization of $8.20 billion, a P/E ratio of -0.95, a P/E/G ratio of 1.36 and a beta of 0.66. The firm has a 50-day moving average price of $9.21 and a 200 day moving average price of $10.02. The company has a current ratio of 0.68, a quick ratio of 0.37 and a debt-to-equity ratio of 0.67.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. The business had revenue of $37.50 billion during the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The business’s revenue was up 5.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.67 EPS. Sell-side analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, December 12th. Investors of record on Monday, November 18th were given a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.53%. The ex-dividend date was Monday, November 18th. Walgreens Boots Alliance’s payout ratio is -9.99%.

Analysts Set New Price Targets

WBA has been the topic of several recent analyst reports. Royal Bank of Canada lowered their target price on shares of Walgreens Boots Alliance from $13.00 to $9.00 and set a “sector perform” rating on the stock in a research note on Wednesday, December 4th. Jefferies Financial Group lowered their price target on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research report on Wednesday, October 23rd. Evercore ISI upped their target price on Walgreens Boots Alliance from $7.50 to $10.00 and gave the stock an “in-line” rating in a research note on Wednesday, October 16th. Truist Financial dropped their price target on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research note on Monday, October 7th. Finally, TD Cowen reduced their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating for the company in a research report on Tuesday, October 22nd. Four analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance currently has a consensus rating of “Hold” and an average price target of $12.58.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.